The World Health Organization will convene an emergency committee on Thursday next week to assess whether the monkeypox outbreak represents a public health emergency of international concern.
Bavarian Nordic raised the company’s financial guidance for 2022 for the third time in a month on Friday after receiving a large order for its monkeypox vaccine by the U.S. Biomedical Advanced Research and Development Authority (BARDA).
There have been more than 1,000 monkeypox cases reported to the World Health Organization in the current outbreak outside the countries in Africa where it more commonly spreads.
Diagnostic companies are racing to develop tests for monkeypox, hoping to tap into a new market as governments ramp up efforts to trace the world’s first major outbreak of the viral infection outside of Africa.
Outbreaks of endemic diseases such as monkeypox and lassa fever are becoming more persistent and frequent, the World Health Organization’s emergencies director, Mike Ryan, warned on Wednesday.
It is not clear yet whether the spread of monkeypox can be contained completely, the World Health Organization said on Tuesday, adding that the WHO’s goal was to contain the outbreak by stopping human-to-human transmission to the maximum extent possible.
The European Union is working on a common purchasing agreement for vaccines and antivirals against monkeypox, as cases of the viral disease usually endemic to Africa gather steam in Europe and beyond.
Countries should take quick steps to contain the spread of monkeypox and share data about their vaccine stockpiles, a senior World Health Organization official said on Friday.
The outbreak of monkeypox cases outside of Africa can be contained, the World Health Organization said on Tuesday, as more governments said they would launch limited vaccinations to combat rising infections of the virus.
Moderna Inc. is testing potential vaccines against monkeypox in preclinical trials as the disease spreads in the United States and Europe.